90 research outputs found

    Saint-Venant's principle in dynamical porous thermoelastic media with memory for heat flux

    Full text link
    In the present paper, we study a linear thermoelastic porous material with a constitutive equation for heat flux with memory. An approximated theory of thermodynamics is presented for this model and a maximal pseudo free energy is determined. We use this energy to study the spatial behaviour of the thermodynamic processes in porous materials. We obtain the domain of influence theorem and establish the spatial decay estimates inside of the domain of influence. Further, we prove a uniqueness theorem valid for finite or infinite body. The body is free of any kind of a priori assumptions concerning the behaviour of solutions at infinity.Comment: 18 pages, accepted on Journal of Thermal Stresse

    On microstretch thermoviscoelastic composite materials

    Get PDF
    In this paper we derive a continuum theory for a thermoviscoelastic composite using an entropy production inequality proposed by Green and Laws, presented in Lagrangian description. The composite is modeled as a mixture of a microstretch viscoelastic material of KelvineVoigt type and a microstretch elastic solid. The strain measures and the basic laws are shown and the thermodynamic restrictions are established. Then the linear theory is considered and the constitutive equations are given in both anisotropic and isotropic cases. Finally, a uniqueness result is established within the framework of the linear theory

    Structure-activity exploration of a small-molecule allosteric inhibitor of T790M/L858R double mutant EGFR

    Get PDF
    EGFR is a protein kinase whose aberrant activity is frequently involved in the development of non-small lung cancer (NSCLC) drug resistant forms. The allosteric inhibition of this enzyme is currently one among the most attractive approaches to design and develop anticancer drugs. In a previous study, we reported the identification of a hit compound acting as type III allosteric inhibitor of the L858R/T790M double mutant EGFR. Herein, we report the design, synthesis and in vitro testing of a series of analogues of the previously identified hit with the aim of exploring the structure-activity relationships (SAR) around this scaffold. The performed analyses allowed us to identify two compounds 15 and 18 showing improved inhibition of double mutant EGFR with respect to the original hit, as well as interesting antiproliferative activity against H1975 NSCLC cancer cells expressing double mutant EGFR. The newly discovered compounds represent promising starting points for further hit-to-lead optimisation

    Maytansinol functionalization:towards useful probes for studying microtubule dynamics

    Get PDF
    11 p.-7 fig.-4 tab. 7 schem.Maytansinoids are a successful class of natural and semisynthetic tubulin binders, known for their potent cytotoxic activity. Their wider application as cytotoxins and chemical probes to study tubulin dynamics has been held back by the complexity of natural product chemistry. Here we report the synthesis of long-chain derivatives and maytansinoid conjugates. We confirmed that bulky substituents do not impact their high activity or the scaffold's binding mode. These encouraging results open new avenues for the design of new maytansine-based probes.This work was supported by the H2020-MSCA-ITN-2019 (860070 TUBINTRAIN), Ministerio de Ciencia e Innovación PID2019-104545RB−I00 (JFD), Proyecto de Investigación en Neurociencia Fundación Tatiana Pérez de Guzmán el Bueno 2020, and by the European Union NextGenerationEU (J.F.D.). Open Access Funding provided by $INSTITUTION within the CRUI-CARE Agreement.Peer reviewe

    Real World Estimate of Vaccination Protection in Individuals Hospitalized for COVID-19

    Get PDF
    Whether vaccination confers a protective effect against progression after hospital admission for COVID-19 remains to be elucidated. Observational study including all the patients admitted to San Paolo Hospital in Milan for COVID-19 in 2021. Previous vaccination was categorized as: none, one dose, full vaccination (two or three doses >14 days before symptoms onset). Data were collected at hospital admission, including demographic and clinical variables, age-unadjusted Charlson Comorbidity index (CCI). The highest intensity of ventilation during hospitalization was registered. The endpoints were in-hospital death (primary) and mechanical ventilation/death (secondary). Survival analysis was conducted by means of Kaplan-Meier curves and Cox regression models. Effect measure modification by age was formally tested. We included 956 patients: 151 (16%) fully vaccinated (18 also third dose), 62 (7%) one dose vaccinated, 743 (78%) unvaccinated. People fully vaccinated were older and suffering from more comorbidities than unvaccinated. By 28 days, the risk of death was of 35.9% (95%CI: 30.1–41.7) in unvaccinated, 41.5% (24.5–58.5) in one dose and 28.4% (18.2–38.5) in fully vaccinated (p = 0.63). After controlling for age, ethnicity, CCI and month of admission, fully vaccinated participants showed a risk reduction of 50% for both in-hospital death, AHR 0.50 (95%CI: 0.30–0.84) and for mechanical ventilation or death, AHR 0.49 (95%CI: 0.35–0.69) compared to unvaccinated, regardless of age (interaction p > 0.56). Fully vaccinated individuals in whom vaccine failed to keep them out of hospital, appeared to be protected against critical disease or death when compared to non-vaccinated. These data support universal COVID-19 vaccination
    corecore